Probiotic Treatment: Professional in-office debridement every 3 months Use of soft-picks® advanced interdental cleaners (Gum®) followed by toothbrushing with ActiVital toothpaste (Gum®) with coenzyme Q10 and sonic daily electric toothbrush (Gum®) twice a day Probiotic supplementation with daily assumption of Limosilactobacillus Reuteri Prodentis® tablet (PerioBalance, Gum®)
Standard Treatment: Professional in-office debridement every 3 months Use of soft-picks® advanced interdental cleaners (Gum®) followed by toothbrushing with ActiVital toothpaste (Gum®) with coenzyme Q10 and sonic daily electric toothbrush (Gum®) twice a day
Study summary
The aim of the study is to assess if probiotic supplementation can be effective in reducing periodontal clinical parameters in a 6-month study on pregnant patients.
Eligibility
Sex
FEMALE
Min age
18 Years
Max age
40 Years
Healthy volunteers
No
Inclusion Criteria:
* women at the 4th month of pregnancy
Exclusion Criteria:
* presence of cardiac pacemaker
* neurological and psychiatric diseases
* patients taking bisphosphonates during the previous 12 months from the beginning of the study
* patients undergoing anticancer therapy.
* patients with poor compliance.
Primary outcome measure(s)
Change in Plaque Index — Baseline, 1, 3 and 6 months Scoring criteria:
0 = no plaque;
1. = thin plaque layer at the gingival margin, only detectable by scraping with a probe;
2. = moderate layer of plaque along the gingival margin; interdental spaces free, but plaque is visible to the naked eye;
3. = abundant plaque along the gingival margin; interdental spaces filled with plaque.
Change in Recession (R) — Baseline, 1, 3 and 6 months Distance (in mm) between the gingival margin and the amelo-cemental junction.
Change in Clinical Attachment Loss (CAL) — Baseline, 1, 3 and 6 months Measurement (in mm) of the position of the gingival margin in relation to the cemento-enamel junction (CEJ).
Change in Bleeding on Probing (BoP) — Baseline, 1, 3 and 6 months Site-specific assessment of the presence or absence of gum bleeding after the insertion of the periodontal probe for the detection of PPD, detected on 6 sites.
Percentage of sites with bleeding on probing determines the BOP%.
Change in Probing Pocket Depth (PPD) — Baseline, 1, 3 and 6 months Evaluation (in mm) of the depth of the gingival sulcus, through a millimeter periodontal probe; it is detected from the gingival margin to the bottom of the gingival sulcus or periodontal pocket, evaluated at 6 sites.
Change in API - Approximal Plaque Index — Baseline, 1, 3 and 6 months Following application of disclosing, a simple yes/no decision is made concerning whether the interproximal surfaces are covered by plaque (+) or not (-). The proportion of plaque-covered interproximal spaces is expressed as a percentage. Usually, in a given quadrant the interproximal spaces are scored from only one aspect (i.e. from the facial - Q2 and Q4 - or from the oral aspect - Q1 and Q3).
Change in Plaque Control Record (PCR%) — Baseline, 1, 3 and 6 months % assessment of the amount of plaque on dental surfaces; it is detected on 4 surfaces: distal, mesial, vestibular, lingual / palatal. The number of sites with plaque is divided by the total number of sites available in the mouth and multiplied by 100. Results indicate the index as a percentage.
Change in Papillary Marginal Gingival Index (PMGI) — Baseline, 1, 3 and 6 months Numerical score from 0 to 3 of gingival inflammation. Papille and gingival margins (vestibular and lingual) are given a score from 0 to 3. The score is given by the total amount of inflamed sites on the total of examined sites.
Change in modified Marginal Gingival Index (mMGI) — Baseline, 1, 3 and 6 months Scoring criteria:
0 = Absence of inflammation
1. = Mild inflammation (marginal or papillary unit)
2. = Mild inflammation (entire marginal and papillary unit)
3. = Moderate inflammation
4. = Severe inflammation
Trial sites (1)
Facility
City
Region
Status
Unit of Dental Hygiene - Section of Dentistry - Department of Clinical, Surgical, Diagnostic and Paediatrics - University of Pavia
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.